Emerging clinical evidences as well as preclinical findings revealed that OGX-011, a CLU inhibitor, could improve the efficacy of chemotherapy through sensitizing cancer cells to drug induced apoptosis [33], [34]. The gene discussed is CLU; the disease is cancer.